000 | 01158 a2200313 4500 | ||
---|---|---|---|
005 | 20250515180010.0 | ||
264 | 0 | _c20090707 | |
008 | 200907s 0 0 eng d | ||
022 | _a1533-4406 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKassimatis, Theodoros I | |
245 | 0 | 0 |
_aRosuvastatin in patients undergoing hemodialysis. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cJul 2009 |
||
300 |
_a93; author reply 94-5 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aCardiovascular Diseases _xmortality |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 |
_aFluorobenzenes _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aKidney Failure, Chronic _xdrug therapy |
650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aRosuvastatin Calcium |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
700 | 1 | _aKonstantinopoulos, Panagiotis A | |
773 | 0 |
_tThe New England journal of medicine _gvol. 361 _gno. 1 _gp. 93; author reply 94-5 |
|
999 |
_c18995081 _d18995081 |